- Products
- Gene
Cat. # | Product name | Source (Host) | Species | Tag | Protein Length | Price |
---|---|---|---|---|---|---|
B2M & HLA-A-894H | Recombinant Human B2M & HLA-A protein(WT-1)(RMFPNAPYL), His-tagged | HEK293 | Human | His | (RMFPNAPYL)&Ile21-Met119&Gly25-Ile308 (Ala269Val) | |
B2M & HLA-A-895H | Recombinant Human B2M & HLA-A protein(HPV16 E7)(YMLDLQPET), His-tagged | HEK293 | Human | His | (YMLDLQPET)&Ile21-Met119&Gly25-Ile308 (Ala269Val) | |
HLA-A/B2M & YLEPGPVTA-769HB | Recombinant Human HLA-A/B2M & YLEPGPVTA protein, His-Avi-tagged, Biotinylated | HEK293 | Human | His-Avi | Gly 25-Thr 305 (HLA-A*0201),Ile21-Met119 (B2M) and YLEPGPVTA peptide | |
TP53-18H | Active Recombinant Human TP53 R175H (HLA-A*02:01) Tetramer Protein, C-His/Avi tagged | HEK293 | Human | C-His/Avi | Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and HMTEVVRHC peptide | |
HLA-A*02:01&B2M&RHAMM-R3-1545H | Recombinant Human HLA-A*02:01&B2M&RHAMM-R3 protein, Biotinylated | HEK293 | Human | N/A | Gly25-Ile308(HLA-A*02:01)&Ile21-Met119(B2M)&ILSLELMKL | |
HLA-A*02:01&B2M&MAGE-A4-1546H | Recombinant Human HLA-A*02:01&B2M&MAGE-A4 protein, Biotinylated | HEK293 | Human | N/A | Gly25-Ile308(HLA-A*02:01)&Ile21-Met119(B2M)&GVYDGREHTVpeptide | |
HLA-A*02:01&B2M&HIV-1547H | Active Recombinant Human HLA-A*02:01&B2M&HIV protein, Biotinylated | HEK293 | Human | N/A | Gly25-Ile308(HLA-A*02:01)&Ile21-Met119(B2M)&SLYNTVATL | |
HLA-A*02:01&B2M&MAGE-A4-1548H | Recombinant Human HLA-A*02:01&B2M&MAGE-A4 protein | HEK293 | Human | N/A | Gly25-Ile308(HLA-A*02:01)&Ile21-Met119(B2M)&KVLEHVVRV | |
HLA-A*02:01&B2M&HBV-1549H | Recombinant Human HLA-A*02:01&B2M&HBV protein, Biotinylated | HEK293 | Human | N/A | Gly25-Ile308(HLA-A*02:01)&Ile21-Met119(B2M)&FLLTRILTI | |
HLA-A*11:01&B2M-1550H | Recombinant Human HLA-A*11:01&B2M protein, Biotinylated | HEK293 | Human | N/A | Gly25-Thr305(HLA-A*11:01)&Ile21-Met119(B2M) | |
HLA-A*02:01&B2M-1551H | Recombinant Human HLA-A*02:01&B2M protein, Biotinylated | HEK293 | Human | N/A | Gly25-Ile308(HLA-A*02:01)&Ile21-Met119(B2M) | |
HLA-A*02:01&B2M&EW-1559H | Recombinant Human HLA-A*02:01&B2M&EW protein, Biotinylated | HEK293 | Human | N/A | Gly25-Ile308(HLA-A*02:01)&Ile21-Met119(B2M)&QLQNPSYDK | |
HLA-A*02:01&B2M&HPV16-E6-1560H | Recombinant Human HLA-A*02:01&B2M&HPV16-E6 protein, PE-Labeled | HEK293 | Human | N/A | Gly25-Ile308(HLA-A*02:01)&Ile21-Met119(B2M)&TIHDIILECV | |
HLA-A*02:01&B2M&CMV pp65-1561H | Recombinant Human HLA-A*02:01&B2M&CMV pp65 protein, Biotinylated | HEK293 | Human | N/A | Gly25-Ile308(HLA-A*02:01)&Ile21-Met119(B2M)&NLVPMVATV | |
HLA-A*02:01&B2M&AFP-1562H | Recombinant Human HLA-A*02:01&B2M&AFP protein, Biotinylated | HEK293 | Human | N/A | Gly25-Ile308(HLA-A*02:01)&Ile21-Met119(B2M)&FMNKFIYEI | |
HLA-A*02:01 & B2M & WT-1-4617H | Recombinant Human HLA-A*02:01 & B2M & WT-1(RMFPNAPYL) protein | HEK293 | Human | N/A | Gly 25 - Thr 305 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & RMFPNAPYL peptide | |
HLA-A*02:01 & B2M & WT-1-4618H | Recombinant Human HLA-A*02:01 & B2M & WT-1(RMFPNAPYL) protein, Biotinylated | HEK293 | Human | N/A | Gly 25 - Thr 305 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & RMFPNAPYL peptide | |
HLA-A*02:01 & B2M & GP100-4619H | Recombinant Human HLA-A*02:01 & B2M & GP100 (YLEPGPVTA) Protein, Biotinylated | HEK293 | Human | N/A | Gly 25 - Thr 305 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & YLEPGPVTA peptide | |
HLA-A*02:01 & B2M & NY-ESO-1-4620H | Active Recombinant Human HLA-A*02:01 & B2M & NY-ESO-1 (SLLMWITQC) Protein, Biotinylated | HEK293 | Human | N/A | Gly 25 - Ile 308 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & SLLMWITQC peptide | |
HLA-A*02:01 & B2M & NY-ESO-1-4621H | Active Recombinant Human HLA-A*02:01 & B2M & NY-ESO-1 (SLLMWITQC) Protein | HEK293 | Human | N/A | Gly 25 - Ile 308 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & SLLMWITQC peptide | |
HLA-A*02:01 & B2M & NY-ESO-1-4622H | Active Recombinant Human HLA-A*02:01 & B2M & NY-ESO-1 (SLLMWITQV) Protein | HEK293 | Human | N/A | Gly 25 - Ile 308 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & SLLMWITQV peptide | |
HLA-A*02:01 & B2M & NY-ESO-1-4623H | Active Recombinant Human HLA-A*02:01 & B2M & NY-ESO-1 (SLLMWITQV) Protein, Biotinylated | HEK293 | Human | N/A | Gly 25 - Ile 308 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & SLLMWITQV peptide | |
HLA-A*0201 | B2M | NY-ESO-1-4665H | Recombinant Human HLA-A*0201 | B2M | NY-ESO-1 (SLLMWITQV) Tetramer Protein, PE-Labeled | HEK293 | Human | N/A | Gly 25 - Ile 308 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & SLLMWITQV peptide | |
HLA-A*0201 | B2M | NY-ESO-1-4666H | Recombinant Human HLA-A*0201 | B2M | NY-ESO-1 (SLLMWITQC) Tetramer Protein, PE-Labeled | HEK293 | Human | N/A | Gly 25 - Ile 308 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & SLLMWITQC peptide | |
MICA-1232H | Recombinant Human MICA Protein, Fc-tagged | HEK293 | Human | Fc |
HLA-A
major histocompatibility complex, class I, A
HLA-A; major histocompatibility complex, class I, A; HLA class I histocompatibility antigen, A-1 alpha chain; antigen presenting molecule; leukocyte antigen class I-A; MHC class I antigen HLA-A heavy chain; HLAA; FLJ26655;
LOC649853
hypothetical protein LOC649853
LOC649853; hypothetical protein LOC649853; Aw 19; HLA class I histocompatibility antigen A-29 alpha chain; HLA-A; major histocompatibility complex class I HLA-A29.1; MHC class I antigen A 29;
YFV
MHC class I antigen
YFV; MHC class I antigen; A-3 alpha chain; 1A03_HUMAN; HLA A; HLA class I; HLA class I histocompatibility antigen; HLA-A; HLAA; Leukocyte antigen class I A; Major histocompatibility complex, class I, A; MHC class I antigen A; MHC class I antigen A*3; MHC class I antigen HLA A heavy chain; class I alpha chain; Y-FA;